Trilogy Capital’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Sell
1,719
-968
-36% -$170K 0.01% 352
2026
Q1
$502K Buy
2,687
+760
+39% +$157K 0.02% 263
2025
Q4
$510K Buy
1,927
+13
+0.7% +$3.23K 0.02% 249
2025
Q3
$454K Sell
1,914
-57
-3% -$14.4K 0.02% 260
2025
Q2
$537K Sell
1,971
-34
-2% -$9.09K 0.03% 229
2025
Q1
$538K Buy
2,005
+225
+13% +$70K 0.03% 216
2024
Q4
$595K Buy
1,780
+24
+1% +$7.66K 0.03% 209
2024
Q3
$481K Buy
1,756
+162
+10% +$41.5K 0.02% 226
2024
Q2
$410K Buy
1,594
+337
+27% +$90.2K 0.02% 232
2024
Q1
$379K Buy
+1,257
New +$363K 0.02% 228
2018
Q4
Sell
-5
Closed -$1K 215
2018
Q3
$1K Hold
5
﹤0.01% 543
2018
Q2
$1K Buy
+5
New +$638 ﹤0.01% 505

Other funds holding CRM

Trilogy Capital's CRM Position: Q2 2026 in Review

Trilogy Capital reduced its Salesforce (CRM) stake by 36% in Q2 2026, selling an estimated $170K and leaving 1,719 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #352.

Trilogy Capital first reported a position in CRM in Q2 2018 and has held it in 12 quarters since. The position peaked at $595K in Q4 2024. 2,472 funds tracked by Wall St. Rank hold CRM as of Q2 2026.

  • Trilogy Capital held 1,719 shares of Salesforce worth $269K as of Q2 2026.
  • Trilogy Capital sold 968 Salesforce shares in Q2 2026, an estimated $170K.
  • Salesforce made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #352 holding.
  • Trilogy Capital first reported a position in Salesforce in Q2 2018 and has held it in 12 quarters since.
  • Trilogy Capital's Salesforce position peaked at $595K in Q4 2024.
  • 2,472 funds tracked by Wall St. Rank held Salesforce as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.